Substitute - Page 10 of 14 - Express Pharma

‘Company should try to free themselves from forex debt and should not hedged future revenues’

‘Indian pharma companies are likely to halt their expansion plans and may wait to execute overseas plans’

‘‘India’’s pharma sector is currently undergoing unprecedented regulatory changes’’

‘’All the changes will lead to better and positive growth’’

‘’Recent regulatory changes are impacting the industry significantly’’

‘’The drugs control dept in almost every state needs a revamp’’

‘‘I believe that beginning 2014 will see a change in the landscape’’

‘’Indian regulatory scenario is far from rosy at these times’’

‘‘Let this be the tipping point, but in a way that is to the benefit of all stakeholders’’

‘’Game cards need to be played with lot of concentration and long-term vision’’